AF Stat Coalition to Present the Costs and Consequences of Atrial Fibrillation by State
March 14, 2011 — Please join us March 22 via webcast as the AF Stat™ Coalition unveils a first-of-its-kind analysis of the impact of atrial fibrillation at the state level. Here’s the invitation and a link to RSVP…
AFib in America: State Impact Reports
A State-by-State Analysis of the Costs and Consequences of a Leading Cardiovascular Condition
RSVP at http://dcwebcasting.com/afstat/
Webcast
March 22, 2011
9:30 – 11:00 a.m. Eastern time
Please join AF Stat™: A Call to Action for Atrial Fibrillation as we unveil the results of AFib in America: State Impact Reports, a first-of-its-kind analysis featuring state level statistics and resources related to the burden of atrial fibrillation (AFib) across the nation. Developed by AF Stat in partnership with The George Washington University School of Public Health and Health Services, the report provides the most comprehensive assessment of the disease to date.
PARTICIPANTS
The Heart of the Matter: An Introduction to Atrial Fibrillation
Keith C. Ferdinand, MD, FACC, FAHA, Clinical Professor, Emory University; Chief Science Officer, Association of Black Cardiologists
AFib in America: The State of the States
Christine C. Ferguson, JD, Professor, School of Public Health and Health Services, Department of Health Policy, The George Washington University
Brian K. Bruen, MS, Lead Research Scientist & Lecturer, School of Public Health and Health Services, Department of Health Policy, The George Washington University
Beyond the Numbers: Understanding the Personal Impact of Atrial Fibrillation
Toni Yancey, MD, MPH, AFib caregiver and Professor in the Department of Health Services, UCLA School of Public Health
Showcasing a State in Action: North Carolina
Peg O’Connell, Fuquay Solutions, member of The Justus-Warren Heart Disease and Stroke Prevention Task Force
The Call to Action: Mobilizing State Stakeholders
Keith Mason, Executive Director, National Forum for Heart Disease and Stroke Prevention
Session will be moderated by Christie Anbar, Chandler Chicco Agency
About AF Stat & AFib
AF Stat™, an initiative sponsored by sanofi-aventis U.S. LLC, is a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by AFib. The most common form of heart arrhythmia, AFib affects approximately 2.5 million Americans, and its prevalence is expected to increase as the U.S. population ages1. AFib is associated with a five-fold increase in risk for stroke2; worsens underlying cardiovascular disease3; doubles the risk of all-cause mortality4; and increases the risk of hospitalization two-to-three fold5. To learn more about AF Stat and AFib visit www.AFStat.com.
1Go, A. Prevalence of Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, May 9, 2001-Vol 285, No. 18.
2 Wolf PA, Abbott RD, Kannel, WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22;983-988.
3 Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257-e354.
4 Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
5 Wattigney WA, et al., Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation.108 (2003); 711-713.